Acetyl-DL-Leucine in Two Individuals with RBD Improves Symptoms

A recent study reported on two individuals with RBD treated with acetyl-DL-leucine (ADLL). Both had significantly decrease in severity of RBD symptoms, with improvements sustained for over 18 months. More intriguingly, both individuals had change in dopamine transporter imaging and brain imaging patterns opposite from what would be expected for Parkinson's disease, suggesting that ADLL might have a neuroprotective effect. Learn more about the ADLL treatment and the study below.